1. In vivo monitoring of the anti-angiogenic therapeutic effect of the pan-deacetylase inhibitor panobinostat by small animal PET in a mouse model of gastrointestinal cancers
   Simone Maschauer et al, 2016, Nuclear Medicine and Biology CrossRef
2. Panobinostat, a histone deacetylase inhibitor, suppresses leptomeningeal seeding in a medulloblastoma animal model
   Ji Hoon Phi et al, 2017, Oncotarget CrossRef
3. Epigenetics of hepatocellular carcinoma
   Tan Boon Toh et al, 2019, Clinical and Translational Medicine CrossRef
4. Current discovery strategies for hepatocellular carcinoma therapeutics
   Qiuzi Dai et al, 2020, Expert Opinion on Drug Discovery CrossRef
5. Histone Deacetylase Inhibitors in the Treatment of Hepatocellular Carcinoma: Current Evidence and Future Opportunities
   Nikolaos Garmpis et al, 2021, Journal of Personalized Medicine CrossRef
6. Optimized Combination of HDACI and TKI Efficiently Inhibits Metabolic Activity in Renal Cell Carcinoma and Overcomes Sunitinib Resistance
   Magdalena Rausch et al, 2020, Cancers CrossRef
7. Genomic Landscape of HCC
   Nia Adeniji et al, 2020, Current Hepatology Reports CrossRef
8. Regioselective Palladium-Catalyzed C-H Bond Trifluoroethylation of Indoles: Exploration and Mechanistic Insight
   Hao Zhang et al, 2018, ACS Catalysis CrossRef
9. Marine-Derived Secondary Metabolites as Promising Epigenetic Bio-Compounds for Anticancer Therapy
   Mariarosaria Conte et al, 2020, Marine Drugs CrossRef
10. Modification of Epigenetic Histone Acetylation in Hepatocellular Carcinoma
    Kwei-Yan Liu et al, 2018, Cancers CrossRef
11. The Value of Anti-angiogenics in Multiple Myeloma Therapy
    Thomas Moehler et al, 2019, Tumor Angiogenesis CrossRef
12. New landscapes and horizons in hepatocellular carcinoma therapy
    Melchiorre Cervello et al, 2020, Aging CrossRef
13. Epigenetic modification-related mechanisms of hepatocellular carcinoma resistance to immune checkpoint inhibition
    Shengwei Tao et al, 2023, Frontiers in Immunology CrossRef
14. Hydroxymethylation and Epigenetic Drugs: New Insights into the Diagnosis and Treatment in Epigenetics of Hepatocellular Carcinoma
    Wei Ouyang et al, 2023, Journal of Oncology CrossRef
15. Angiogenesis inhibitors as therapeutic agents in cancer: Challenges and future directions
    Zhexuan Lin et al, 2016, European Journal of Pharmacology CrossRef
16. The Value of Anti-Angiogenics in Multiple Myeloma Therapy
    Thomas Moehler et al, 2017, Tumor Angiogenesis CrossRef
17. Histone deacetylase inhibitors in hepatocellular carcinoma: A therapeutic perspective
    Diamantis I. Tsilimigras et al, 2018, Surgical Oncology CrossRef
18. DNA and Histone Methylation in Liver Cancer
    Eri Arai et al, 2017, DNA and Histone Methylation as Cancer Targets CrossRef
19. 3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy
    Sara Rezzola et al, 2017, Angiogenesis CrossRef